Denali Therapeutics (DNLI) Receives a Buy from Bank of America Securities
In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Denali Therapeutics (DNLI – Research Report), with a price target of $28.00. The company's shares closed yesterday at $13.96.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Ahmad covers the Healthcare sector, focusing on stocks such as Sarepta Therapeutics, PTC Therapeutics, and Alnylam Pharma. According to TipRanks, Ahmad has an average return of -5.3% and a 43.00% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Denali Therapeutics with a $32.60 average price target, which is a 133.52% upside from current levels. In a report released on May 8, Robert W. Baird also maintained a Buy rating on the stock with a $29.00 price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
25 minutes ago
- Business Insider
Boeing (BA) Receives a Rating Update from a Top Analyst
In a report released yesterday, Gautam Khanna from TD Cowen reiterated a Buy rating on Boeing (BA – Research Report), with a price target of $230.00. The company's shares closed yesterday at $215.73. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Khanna is a top 25 analyst with an average return of 17.4% and a 73.09% success rate. Khanna covers the Industrials sector, focusing on stocks such as Boeing, Booz Allen, and ATI. Currently, the analyst consensus on Boeing is a Strong Buy with an average price target of $220.95, implying a 2.42% upside from current levels. In a report released yesterday, UBS also maintained a Buy rating on the stock with a $245.00 price target. The company has a one-year high of $218.80 and a one-year low of $128.88. Currently, Boeing has an average volume of 9.13M. Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BA in relation to earlier this year. Last month, Brendan J. Nelson, the SVP, President, Boeing Global of BA sold 640.00 shares for a total of $132,019.20.
Business Insider
an hour ago
- Business Insider
Zuckerberg Writes a $14B Check to Catch Up in the AI Race
Social media giant Meta Platforms (META) is making its biggest move yet in the AI race. CEO Mark Zuckerberg is set to invest $14 billion in Scale AI, a top data-labeling startup, according to The Information. The deal would give Meta a 49% stake in Scale AI, without gaining full control of the company. Along with the stake, Meta will bring on Scale's founder, Alexandr Wang. He will help lead a new AI lab at Meta. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter This move highlights Zuckerberg's push to regain ground against leading AI players like OpenAI and Google, owned by Alphabet (GOOGL). It should be noted that Meta's recent launch of Llama 4 (its large language AI model) received a lukewarm response, and its more advanced 'Behemoth' model is yet to be launched. By bringing in Alexandr Wang, a proven AI builder with strong business skills, Meta hopes to refocus its strategy and accelerate progress across both research and AI products. Wang Set to Steer Meta's AI Push Zuckerberg sees Wang as someone who can lead in tough times. Wang knows both the tech and the business side of AI. He built Scale AI from scratch. The company helps train AI systems by labeling huge amounts of data. It works with OpenAI, Google, Microsoft (MSFT), and even the U.S. defense sector. Insiders say Zuckerberg sees Wang as a 'wartime CEO.' He's betting that Wang can realign Meta's AI plans and help it leap ahead. Zuckerberg's Boldest AI Move Yet Meta is not buying Scale AI outright, and that's a clear strategic choice. The company is under watch by U.S. regulators, who are already questioning its market power. A full takeover could trigger more legal trouble for the social media giant. So instead, Meta plans to take a 49% stake. This way, it gains access to Scale's top talent and tools without taking full control. In addition, it's a smart way for Meta to bring in fresh expertise from outside the company. Scale's founder, Alexandr Wang, will help lead Meta's new AI lab and will be joined by some of his top engineers. Other tech giants have done the same in the past. Instead of full takeovers, companies like Google and Microsoft have taken large stakes in AI startups such as and Inflection AI. This strategy allows them to tap into top talent and cutting-edge tools without triggering strict regulatory reviews. For Meta, the deal is about much more than money. It's a way to strengthen its AI roadmap, which has struggled to keep pace. With Scale's tools and team, Meta hopes to close the gap with OpenAI and other fast-moving rivals. Is Meta a Buy, Sell, or Hold? Turning to Wall Street, analysts have a Strong Buy consensus rating on META stock based on 42 Buys, three Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average META price target of $698.07 per share implies that shares are fairly valued.
Business Insider
an hour ago
- Business Insider
Warner Bros (WBD) Receives a Buy from Guggenheim
In a report released yesterday, from Guggenheim maintained a Buy rating on Warner Bros (WBD – Research Report). The company's shares closed yesterday at $10.01. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter In addition to Guggenheim, Warner Bros also received a Buy from TD Cowen's Doug Creutz in a report issued yesterday. However, on the same day, Bernstein maintained a Hold rating on Warner Bros (NASDAQ: WBD).
